UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006653
Receipt number R000007866
Scientific Title Trabecular Metal Primary Hip Prosthesis Registry Study -Multicenter clinical research in Japan and US-
Date of disclosure of the study information 2011/11/04
Last modified on 2020/11/24 09:44:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Trabecular Metal Primary Hip Prosthesis Registry Study -Multicenter clinical research in Japan and US-

Acronym

TM Stem Registry Study -Multicenter clinical research in Japan and US

Scientific Title

Trabecular Metal Primary Hip Prosthesis Registry Study -Multicenter clinical research in Japan and US-

Scientific Title:Acronym

TM Stem Registry Study -Multicenter clinical research in Japan and US

Region

Japan North America


Condition

Condition

Patients who have been diagnosed Osteoarthritis, Rheumatoid Arthritis and Avascular Necrosis, etc.

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To obtain preoperative, operative and postoperative clinical outcomes and radiographic data on the Trabecular Metal Primary Hip Prosthesis used in primary or revision total hip arthroplasty.

Basic objectives2

Others

Basic objectives -Others

To pool the clinical data.

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

To obtain preoperative, operative and postoperative clinical outcomes and radiographic data

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Trabecular Metal Primary Hip Prosthesis by THA

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.atient is &#8805; 18 years of age.
2.Patient is in stable health and able to undergo surgery.
3.Patient suffers from severe hip pain and disability requiring total, hemi or revision hip replacement.
4.Patient is willing and able to cooperate in prescribed post-operative therapy.
5.Patient is willing and able to complete scheduled follow-up evaluations as described in the Informed Consent.
6.Patient has participated in the Informed Consent process and has signed an IRB approved Informed Consent.

Key exclusion criteria

1.Patient is &#8805; 18 years of age.
2.Patient with an acute, chronic, local or systemic infection.
3.Patient is skeletally immature.
4.Patient is pregnant.
5.Patient is a prisoner, mentally incompetent and/or anticipated to be non-compliant.
6.Patient has a known allergy to one of the constituents of the implant, e.g. cobalt, chromium, nickel, etc.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kazuo
Middle name
Last name Hirakawa

Organization

Shonan Kamakura Joint Reconstruction Center

Division name

Department of Orthopaedic Surgery

Zip code

247-0061

Address

5-4-17, Dai, Kamakura, Kanagawa prefecture, Japan

TEL

0467-47-2377

Email

mail@skjrc.jp


Public contact

Name of contact person

1st name Kazuo
Middle name
Last name Hirakawa

Organization

Shonan Kamakura Joint Reconstruction Center

Division name

Department of Orthopaedic Surgery

Zip code

247-0061

Address

5-4-17, Dai, Kamakura, Kanagawa prefecture, Japan

TEL

0467-47-2377

Homepage URL


Email

akikun@jcom.home.ne.jp


Sponsor or person

Institute

Shonan Kamakura Joint Reconstruction Center

Institute

Department

Personal name



Funding Source

Organization

Zimmer Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mirai Iryo Research Center

Address

1-8-7, Koji-machi, Chiyoda-ku, Tokyo 102-0083, Japan

Tel

0332634801

Email

mirai-ec1@mirai-iryo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人 沖縄徳洲会 湘南鎌倉人工関節センター


Other administrative information

Date of disclosure of the study information

2011 Year 11 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2011 Year 10 Month 12 Day

Date of IRB


Anticipated trial start date

2011 Year 11 Month 01 Day

Last follow-up date

2023 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 11 Month 02 Day

Last modified on

2020 Year 11 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007866